Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1960 2
1961 1
1963 1
1964 2
1966 1
1968 1
1969 1
1970 3
1971 4
1972 2
1973 4
1974 6
1975 3
1976 2
1977 7
1979 8
1980 1
1981 2
1982 3
1983 4
1984 1
1985 4
1986 3
1987 2
1989 2
1990 1
1991 2
1992 1
1993 1
1994 5
1995 1
1996 4
1997 1
1998 2
1999 1
2000 3
2001 2
2002 1
2006 1
2007 1
2008 1
2009 3
2010 2
2011 2
2012 1
2013 2
2014 5
2015 1
2016 1
2017 2
2018 1
2019 1
2020 2
2021 8
2022 5
2023 7
2024 4
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
Incontinence.
Heller BR, Whitehead WE, Johnson LD. Heller BR, et al. Among authors: johnson ld. J Gerontol Nurs. 1989 May;15(5):16-23. doi: 10.3928/0098-9134-19890501-05. J Gerontol Nurs. 1989. PMID: 2656834 Review.
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy.
Krishnamoorthy M, Seelige R, Brown CR, Chau N, Nielsen Viller N, Johnson LDS, Linderoth E, Wang JCY, Dillon CP, Abayasiriwardana K, Lees C, Wong M, Kaneda MM, Uger RA, Lin GHY. Krishnamoorthy M, et al. Among authors: johnson lds. Front Immunol. 2025 Feb 26;16:1518787. doi: 10.3389/fimmu.2025.1518787. eCollection 2025. Front Immunol. 2025. PMID: 40078999 Free PMC article.
Targeting CD47 in Sézary syndrome with SIRPαFc.
Johnson LDS, Banerjee S, Kruglov O, Viller NN, Horwitz SM, Lesokhin A, Zain J, Querfeld C, Chen R, Okada C, Sawas A, O'Connor OA, Sievers EL, Shou Y, Uger RA, Wong M, Akilov OE. Johnson LDS, et al. Blood Adv. 2019 Apr 9;3(7):1145-1153. doi: 10.1182/bloodadvances.2018030577. Blood Adv. 2019. PMID: 30962222 Free PMC article. Clinical Trial.
Improved Binding Affinity and Pharmacokinetics Enable Sustained Degradation of BCL6 In Vivo.
Huckvale R, Harnden AC, Cheung KJ, Pierrat OA, Talbot R, Box GM, Henley AT, de Haven Brandon AK, Hallsworth AE, Bright MD, Akpinar HA, Miller DSJ, Tarantino D, Gowan S, Hayes A, Gunnell EA, Brennan A, Davis OA, Johnson LD, de Klerk S, McAndrew C, Le Bihan YV, Meniconi M, Burke R, Kirkin V, van Montfort RLM, Raynaud FI, Rossanese OW, Bellenie BR, Hoelder S. Huckvale R, et al. Among authors: johnson ld. J Med Chem. 2022 Jun 23;65(12):8191-8207. doi: 10.1021/acs.jmedchem.1c02175. Epub 2022 Jun 2. J Med Chem. 2022. PMID: 35653645 Free PMC article.
148 results